TargetGenome polyprotein(Human rhinovirus B)
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 700nMAssay Description:Inhibitory activity against HCMV protease by HPLC assayMore data for this Ligand-Target Pair
TargetGenome polyprotein(Human rhinovirus B)
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 720nMAssay Description:Inhibitory activity against HCMV protease by HPLC assayMore data for this Ligand-Target Pair
TargetGenome polyprotein(Human rhinovirus B)
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 730nMAssay Description:Inhibitory activity against HCMV protease by SPA assayMore data for this Ligand-Target Pair
TargetGenome polyprotein(Human rhinovirus B)
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 800nMAssay Description:Inhibitory activity against HCMV protease by SPA assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of [3H]Rev response element binding to HIV1 biotinylated-Rev protein expressed in Escherichia coli after 15 mins by scintillation proximit...More data for this Ligand-Target Pair
TargetGenome polyprotein(Human rhinovirus B)
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.45E+3nMAssay Description:Inhibitory activity against HCMV protease by SPA assayMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.70E+3nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.80E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetGenome polyprotein(Human rhinovirus B)
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 2.68E+3nMAssay Description:Inhibitory activity against HCMV protease by SPA assayMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 3.10E+3nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 3.80E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetGenome polyprotein(Human rhinovirus B)
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 3.90E+3nMAssay Description:Inhibitory activity against HCMV protease by SPA assayMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 4.10E+3nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 4.30E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 4.70E+3nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetGenome polyprotein(Human rhinovirus B)
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 4.80E+3nMAssay Description:Inhibitory activity against HCMV protease by HPLC assayMore data for this Ligand-Target Pair
TargetGenome polyprotein(Human rhinovirus B)
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 5.30E+3nMAssay Description:Inhibitory activity against HCMV protease by HPLC assayMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 5.50E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
Affinity DataIC50: 6.00E+3nMAssay Description:Inhibition of [3H]Rev response element binding to HIV1 biotinylated-Rev protein expressed in Escherichia coli after 15 mins by scintillation proximit...More data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 6.70E+3nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 6.90E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 7.30E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 7.40E+3nMAssay Description:Compound was evaluated for inhibition of HIV-2 reverse transcriptase using rC.dG and [3H]-dGTP as substrates at 100 microg/mlMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 8.30E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 8.50E+3nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 8.70E+3nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 8.70E+3nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 9.00E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 9.00E+3nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 9.00E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 9.00E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetGenome polyprotein(Human rhinovirus B)
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 9.10E+3nMAssay Description:Inhibitory activity against HCMV protease by HPLC assayMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 9.20E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 9.60E+3nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetO94806/P05129/P05771/P17252/P24723/P41743/Q02156/Q04759/Q05513/Q05655/Q15139(Homo sapiens (Human))
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of protein kinase CMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.06E+4nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.20E+4nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetGenome polyprotein(Human rhinovirus B)
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Glaxowellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.24E+4nMAssay Description:Inhibitory activity against HCMV protease by SPA assayMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.40E+4nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.40E+4nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.50E+4nMAssay Description:Evaluated for inhibition of HIV-2 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.50E+4nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
Affinity DataIC50: 1.70E+4nMAssay Description:Inhibition of [3H]Rev response element binding to HIV1 biotinylated-Rev protein expressed in Escherichia coli after 15 mins by scintillation proximit...More data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.80E+4nMAssay Description:Compound was evaluated for inhibition of HIV-1 reverse transcriptase using rC.dG and [3H]-dGTP as substrates at 100 ug/mLMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.90E+4nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
TargetReverse transcriptase/RNaseH(Human immunodeficiency virus 1)
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Glaxowellcome Medicines Research Center
Curated by ChEMBL
Affinity DataIC50: 1.90E+4nMAssay Description:Evaluated for inhibition of HIV-1 reverse transcriptaseMore data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+4nMAssay Description:Inhibition of [3H]Rev response element binding to HIV1 biotinylated-Rev protein expressed in Escherichia coli after 15 mins by scintillation proximit...More data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+4nMAssay Description:Inhibition of [3H]Rev response element binding to HIV1 biotinylated-Rev protein expressed in Escherichia coli after 15 mins by scintillation proximit...More data for this Ligand-Target Pair
TargetGenome polyprotein/Non-structural protein 4A(Hepatitis C virus)
Glaxosmithkline
Curated by ChEMBL
Glaxosmithkline
Curated by ChEMBL
Affinity DataIC50: 1.90E+4nMAssay Description:Inhibitory concentration against hepatitis C virus NS3/4A protease on 18 hr preincubation in chromogenic assayMore data for this Ligand-Target Pair